## Mechanism: 
- IL6 receptor antagonist bDMARD: 
	- binds to both soluble and membrane-bound IL6 receptors âž” inhibiting IL6-mediated signaling 
## Indications: 
- rheumatoid arthritis 
## Adverse Effects: 
- infection, neutropenia, thrombocytopenia, and anemia